Upstream Bio Inc’s filing revealed that its Director Chimovits Erez acquired Company’s shares for reported $14.03 million on Oct 15 ’24. In the deal valued at $17.00 per share,825,000 shares were bought. As a result of this transaction, Chimovits Erez now holds 4,554,873 shares worth roughly $86.59 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ORBIMED ADVISORS LLC bought 825,000 shares, generating $14,025,000 in total proceeds. Upon buying the shares at $17.00, the Director now owns 4,554,873 shares.
Before that, AI Upstream LLC bought 1,175,000 shares. Upstream Bio Inc shares valued at $19,975,000 were divested by the 10% Owner at a price of $17.00 per share. As a result of the transaction, AI Upstream LLC now holds 1,175,000 shares, worth roughly $22.34 million.
William Blair initiated its Upstream Bio Inc [UPB] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. Piper Sandler began covering UPB with “an Overweight” recommendation on November 05, 2024. JP Morgan started covering the stock on November 05, 2024. It rated UPB as “an Overweight”.
Price Performance Review of UPB
On Monday, Upstream Bio Inc [NASDAQ:UPB] saw its stock fall -6.12% to $19.01. Over the last five days, the stock has lost -14.37%. Upstream Bio Inc shares have fallen nearly -13.59% since the year began.
Levels Of Support And Resistance For UPB Stock
The 24-hour chart illustrates a support level at 17.73, which if violated will result in even more drops to 16.46. On the upside, there is a resistance level at 20.61. A further resistance level may holdings at 22.22. The Relative Strength Index (RSI) on the 14-day chart is 38.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.52%. Stochastics %K at 28.64% indicates the stock is a holding.
How much short interest is there in Upstream Bio Inc?
A steep rise in short interest was recorded in Upstream Bio Inc stocks on 2024-11-29, growing by 0.56 million shares to a total of 1.21 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 0.65 million shares. There was a rise of 46.34%, which implies that there is a positive sentiment for the stock.
